David S. Hage, James Hewett University Professor at the University of Nebraska–Lincoln, discusses how advances in affinity-based separations are shaping the future of personalized medicine and ...
Take up a new role at the workplace, and you will see the changes happening around.
ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) Estimate 55% of patients with MSS CRC have high plasma TMB, representing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback